DrugPatentWatch Database Preview
Avelumab - Biologic Drug Details
Summary for avelumab
| Tradenames: | 1 |
| Patents: | 8 |
| Applicants: | 1 |
| BLAs: | 2 |
| Suppliers: see list | 1 |
US Patents for avelumab
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emd Serono Inc | BAVENCIO | avelumab | INJECTABLE;INJECTION | 761049 | 001 | 2017-04-25 | ➤ Sign Up | Celgene Corporation (Summit, NJ) The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, DC) | ➤ Sign Up | RX | Orphan | search |
| Emd Serono Inc | BAVENCIO | avelumab | INJECTABLE;INJECTION | 761049 | 001 | 2017-04-25 | ➤ Sign Up | ModernaTX, Inc. (Cambridge, MA) | ➤ Sign Up | RX | Orphan | search |
| Emd Serono Inc | BAVENCIO | avelumab | INJECTABLE;INJECTION | 761049 | 001 | 2017-04-25 | ➤ Sign Up | ➤ Sign Up | RX | Orphan | search | |
| Emd Serono Inc | BAVENCIO | avelumab | INJECTABLE;INJECTION | 761049 | 001 | 2017-04-25 | ➤ Sign Up | Biomed Valley Discoveries, Inc. (Kansas City, MO) | ➤ Sign Up | RX | Orphan | search |
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
International Patents for avelumab
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Russian Federation | 2016139974 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 2015126548 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 2014028560 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 2017210058 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
